A novel three-long noncoding RNA risk score system for the prognostic prediction of triple-negative breast cancer

Biomark Med. 2021 Jan;15(1):43-55. doi: 10.2217/bmm-2020-0505.

Abstract

Background: Triple-negative breast cancer (TNBC) is characterized by fast tumor increase, rapid recurrence and natural metastasis. We aimed to identify a genetic signature for predicting the prognosis of TNBC. Materials & methods: We conducted a weighted correlation network analysis of datasets from the Gene Expression Omnibus. Multivariate Cox regression was used to construct a risk score model. Results: The multi-factor risk scoring model was meaningfully associated with the prognosis of patients with TBNC. The predictive power of the model was demonstrated by the time-dependent receiver operating characteristic curve and Kaplan-Meier curve, and verified using a validation set. Conclusion: We established a long noncoding RNA-based model for the prognostic prediction of TNBC.

Keywords: GEO; TCGA; WGCNA; biomarker; long non-coding RNA; survival analysis; triple-negative breast cancer.

MeSH terms

  • Biomarkers, Tumor
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Middle Aged
  • Prognosis
  • RNA, Long Noncoding*
  • Triple Negative Breast Neoplasms*

Substances

  • Biomarkers, Tumor
  • RNA, Long Noncoding